LEADER 02506nam 2200457 450 001 9910138348803321 005 20240125190729.0 010 $a953-51-6885-1 035 $a(CKB)3230000000075551 035 $a(NjHacI)993230000000075551 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/65772 035 $a(EXLCZ)993230000000075551 100 $a20221010d2012 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAntiviral drugs $easpects of clinical use and recent advances /$fedited by Patrick Arbuthnot 210 $cIntechOpen$d2012 210 1$a[Place of publication not identified] :$cInTech,$d[2012] 210 4$dİ2012 215 $a1 online resource (208 pages) $cillustrations 311 $a953-51-0256-7 320 $aIncludes bibliographical references. 330 $aThe articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the book. The first part reviews the treatment of hepatitis C virus infection, the management of virus-related acute retinal necrosis, the use of leflunomide therapy in renal transplant patients, and mathematical modeling of HIV-1 treatment responses. Basic research topics are dealt with in the second half of the book. New developments in the treatment of the influenza virus, the use of animal models for HIV-1 drug development, the use of single chain camelid antibodies against negative strand RNA viruses, countering norovirus infection, and the use of plant extracts to treat herpes simplex virus infection are described. The content of the book is not intended to be comprehensive, but aims to provide the reader with insights into selected aspects of established and new viral therapies. 517 $aAntiviral drugs 606 $aAntiviral agents 606 $aVirus diseases$xChemotherapy 610 $aPharmacology 615 0$aAntiviral agents. 615 0$aVirus diseases$xChemotherapy. 676 $a616.925061 700 $aArbuthnot$b Patrick$4edt$01466719 702 $aArbuthnot$b Patrick 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910138348803321 996 $aAntiviral drugs$93870880 997 $aUNINA